{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:36:34Z","timestamp":1787009794392,"version":"build-2736575974"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1097\/01.iae.0000231376.76601.40","type":"journal-article","created":{"date-parts":[[2007,2,8]],"date-time":"2007-02-08T04:04:17Z","timestamp":1170907457000},"page":"222-235","source":"Crossref","is-referenced-by-count":24,"title":["IMMUNOREACTIVE ENDOTHELIN-1 IN THE VITREOUS HUMOR AND EPIRETINAL MEMBRANES OF PATIENTS WITH PROLIFERATIVE DIABETIC RETINOPATHY"],"prefix":"10.1097","volume":"27","author":[{"given":"MANUELA","family":"ROLD\u00c1N-PALLAR\u00c9S","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAQUEL","family":"ROLL\u00cdN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JUAN CARLOS","family":"MART\u00cdNEZ-MONTERO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ARTURO","family":"FERN\u00c1NDEZ-CRUZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CARMEN","family":"BRAVO-LLATA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RAQUEL","family":"FERN\u00c1NDEZ-DURANGO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210130","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1007\/s001250051296","article-title":"Diabetes-induced vascular dysfunction in the retina: role of endothelins.","volume":"42","author":"Deng","year":"1999","journal-title":"Diabetologia"},{"key":"R2-14-20210130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/83241","article-title":"Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation.","volume":"7","author":"Soriano","year":"2001","journal-title":"Nat Med"},{"key":"R3-14-20210130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelium growth factor.","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr Rev"},{"key":"R4-14-20210130","first-page":"22","article-title":"Biological role of fibroblast growth factor-2.","volume":"18","author":"Bikfalvi","year":"1997","journal-title":"Endocr Rev"},{"key":"R5-14-20210130","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with retinopathy and other retinal disorders.","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"R6-14-20210130","first-page":"574","article-title":"Vascular endothelial growth factor\/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.","volume":"145","author":"Miller","year":"1994","journal-title":"Am J Pathol"},{"key":"R7-14-20210130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.HYP.32.1.89","article-title":"Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression.","volume":"32","author":"Matsuura","year":"1998","journal-title":"Hypertension"},{"key":"R8-14-20210130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells.","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"key":"R9-14-20210130","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/348730a0","article-title":"Cloning and expression of a cDNA encoding an endothelin receptor.","volume":"348","author":"Arai","year":"1990","journal-title":"Nature"},{"key":"R10-14-20210130","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/348732a0","article-title":"Cloning of a cDNA encoding a non-isopeptide selective subtype of endothelin receptor.","volume":"348","author":"Sakurai","year":"1990","journal-title":"Nature"},{"key":"R11-14-20210130","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0014-4835(02)00312-3","article-title":"Regulation of human retinal blood flow by endothelin-1.","volume":"76","author":"Polak","year":"2003","journal-title":"Exp Eye Res"},{"key":"R12-14-20210130","first-page":"2949","article-title":"Effect of endothelin and BQ123 on ocular blood flow parameters in healthy subjects.","volume":"42","author":"Polak","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-14-20210130","first-page":"2340","article-title":"Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery.","volume":"33","author":"Haefliger","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-14-20210130","first-page":"686","article-title":"Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors.","volume":"38","author":"Morbidelli","year":"1995","journal-title":"Am J Physiol"},{"key":"R15-14-20210130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1440-1681.1999.03029.x","article-title":"Co-operation between endothelin and nitric oxide in promoting endothelial cell migration and angiogenesis.","volume":"26","author":"Goligorsky","year":"1999","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R16-14-20210130","doi-asserted-by":"crossref","first-page":"10112","DOI":"10.1016\/S0021-9258(17)36997-1","article-title":"Constitutive endothelin-1 overexpression promotes smooth muscle cells proliferation via an external autocrine loop.","volume":"269","author":"Alberts","year":"1994","journal-title":"J Biol Chem"},{"key":"R17-14-20210130","first-page":"720","article-title":"Expression of endothelin-1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumour growth.","volume":"59","author":"Bagnato","year":"1999","journal-title":"Cancer Res"},{"key":"R18-14-20210130","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1172\/JCI115367","article-title":"Hypoxia induces endothelin gene expression and secretion in cultured human endothelium.","volume":"88","author":"Kourembanas","year":"1991","journal-title":"J Clin Invest"},{"key":"R19-14-20210130","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0008-6363(95)00164-6","article-title":"Cell specificity and signalling pathway of endothelin-1 gene regulation by hypoxia.","volume":"30","author":"Bodi","year":"1995","journal-title":"Cardiovasc Res"},{"key":"R20-14-20210130","doi-asserted-by":"crossref","first-page":"17097","DOI":"10.1074\/jbc.272.27.17097","article-title":"Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion.","volume":"272","author":"Pedram","year":"1997","journal-title":"J Biol Chem"},{"key":"R21-14-20210130","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0002-9440(10)64807-9","article-title":"Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo.","volume":"157","author":"Salani","year":"2000","journal-title":"Am J Pathol"},{"key":"R22-14-20210130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0006-8993(01)02731-7","article-title":"Localisation of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eyes. Evidence for endothelin-1 expression in astrocytes.","volume":"912","author":"Ripodas","year":"2001","journal-title":"Brain Res"},{"key":"R23-14-20210130","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s001250051375","article-title":"Changes in the density and localization of endothelin receptors in the early stages of rat diabetic retinopathy and the effect of insulin treatment.","volume":"43","author":"De Juan","year":"2000","journal-title":"Diabetologia"},{"key":"R24-14-20210130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.pu.17.050196.001033","article-title":"Diabetic retinopathy.","volume":"17","author":"Klein","year":"1996","journal-title":"Annu Rev Public Health"},{"key":"R25-14-20210130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0002-9394(98)00309-2","article-title":"Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no 24. Early Treatment Diabetic Retinopathy Study Research Group.","volume":"127","author":"Fong","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R26-14-20210130","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0002-9394(14)72066-5","article-title":"Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes.","volume":"122","author":"Frank","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"R27-14-20210130","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI116877","article-title":"Vitreous levels of the insulin-like growth factor I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease: studies in nondiabetic and diabetic subjects.","volume":"92","author":"Meyer-Schwickerath","year":"1993","journal-title":"J Clin Invest"},{"key":"R28-14-20210130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-8993(95)00578-E","article-title":"Identification of receptor subtypes in rat retina using subtype-selective ligands.","volume":"690","author":"De Juan","year":"1995","journal-title":"Brain Res"},{"key":"R29-14-20210130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the folin phenol reagent.","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"R30-14-20210130","first-page":"461","article-title":"Immunoreactive ET-1 in the vitreous humour and epiretinal membranes of patients with proliferative vitreoretinopathy.","volume":"11","author":"Rold\u00e1n-Pallar\u00e9s","year":"2005","journal-title":"Mol Vis"},{"key":"R31-14-20210130","first-page":"103","article-title":"Localization of endothelin-1 mRNA expression and immunoreactivity in the anterior segment of human eye: expression of ETA and ETB receptors.","volume":"9","author":"Fernandez-Durango","year":"2003","journal-title":"Mol Vis"},{"key":"R32-14-20210130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2337\/diab.32.2.S20","article-title":"Studies on the pathophysiology of diabetic retinopathy. The blood-retinal barrier in diabetes.","volume":"32","author":"Cunha-Vaz","year":"1983","journal-title":"Diabetes"},{"key":"R33-14-20210130","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00006982-199515040-00011","article-title":"Retinal oxygen distribution: its role in the physiopathology of vasoproliferative microangiopathies.","volume":"15","author":"Pournaras","year":"1995","journal-title":"Retina"},{"key":"R34-14-20210130","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1167\/iovs.03-0387","article-title":"Endothelin-1 synthesis and secretion in human retinal pigment epithelial cells (ARPE- 19). Differential regulation by cholinergics and TNF-\u03b1.","volume":"44","author":"Narayan","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R35-14-20210130","doi-asserted-by":"crossref","first-page":"S378","DOI":"10.1097\/00005344-199800001-00107","article-title":"Immunoreactive endothelin levels in the vitreous fluid are decreased in diabetic patients with proliferative retinopathy.","volume":"31","author":"Ogata","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"R36-14-20210130","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/00006982-200112000-00013","article-title":"Possible involvement of endothelin-1 and nitric oxide in the pathogenesis of proliferative diabetic retinopathy.","volume":"21","author":"Oku","year":"2001","journal-title":"Retina"},{"key":"R37-14-20210130","first-page":"157","article-title":"The Endothelium in Cardiovascular Disease.","author":"Fern\u00e1ndez- Cruz","year":"1995"},{"key":"R38-14-20210130","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.2337\/diacare.15.10.1396","article-title":"Increased plasma endothelin in NIDDM patients with retinopathy.","volume":"15","author":"Kawamura","year":"1992","journal-title":"Diabetes Care"},{"key":"R39-14-20210130","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1055\/s-0029-1211795","article-title":"Increased levels of plasma endothelin-1 in insulin dependent diabetic patients with retinopathy but without other diabetes related organ damage.","volume":"105","author":"Laurenti","year":"1997","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R40-14-20210130","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0039-6257(92)90115-A","article-title":"Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy and retinal degeneration.","volume":"36","author":"Wiedemann","year":"1992","journal-title":"Surv Ophthalmol"},{"key":"R41-14-20210130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0002-9394(78)90289-1","article-title":"Neovasculogenic ability of prostaglandins, growth factors and synthetic chemoattractant.","volume":"86","author":"BenEzra","year":"1978","journal-title":"Am J Ophthalmol"},{"key":"R42-14-20210130","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archopht.1986.01050230123046","article-title":"Intravitreal chemotactic and mitogenic activity: implication of blood-retinal barrier breakdown.","volume":"104","author":"Campochiaro","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"R43-14-20210130","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1001\/archopht.1984.01040031488029","article-title":"Serum contains chemoattractants for human retinal pigment epithelial cells.","volume":"102","author":"Campochiaro","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"R44-14-20210130","first-page":"839","article-title":"Growth factor responsiveness of human retinal pigment epithelial cells.","volume":"31","author":"Leschey","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R45-14-20210130","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archopht.1994.01090210119024","article-title":"Endothelin receptor- binding subtypes in the human retina and choroids.","volume":"112","author":"McCumber","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"R46-14-20210130","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2337\/diabetes.49.7.1239","article-title":"Induction of endothelin-1 expression by glucose. An effect of protein kinase C activation.","volume":"49","author":"Park","year":"2000","journal-title":"Diabetes"},{"key":"R47-14-20210130","first-page":"2504","article-title":"Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1.","volume":"37","author":"Takagi","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R48-14-20210130","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.","volume":"92","author":"Aiello","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"R49-14-20210130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archopht.1996.01100130062010","article-title":"Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization.","volume":"114","author":"Adamis","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"R50-14-20210130","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0002-9440(10)65430-2","article-title":"Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor.","volume":"154","author":"Seo","year":"1999","journal-title":"Am J Pathol"},{"key":"R51-14-20210130","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2337\/diab.46.9.1473","article-title":"Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective \u03b2-isoform-selective inhibitor.","volume":"46","author":"Aiello","year":"1997","journal-title":"Diabetes"},{"key":"R52-14-20210130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0895-7061(96)00250-6","article-title":"Effects of protein kinase C activation and inhibition on endothelin-1 release from human aortic and pulmonary artery endothelial cells: comparison with effects on bovine endothelin-1 and human prostaglandin I2 release.","volume":"10","author":"Yamada","year":"1997","journal-title":"Am J Hypertens"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.iae.0000231376.76601.40","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T16:27:06Z","timestamp":1621873626000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-200702000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.iae.0000231376.76601.40","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}